BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-293@pharmaconomics
DTSTAMP:20260707T003341Z
DTSTART;VALUE=DATE:20260729
DTEND;VALUE=DATE:20260730
SUMMARY:OTLK PDUFA — ONS-5010
DESCRIPTION:The FDA's approval decision on ONS-5010 for bevacizumab-vikg is due Jul 29\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1649989/000110465926074346/tm2618010d1_8k.htm\n\nTrack it: https://pharmaconomics.com/e/293
URL:https://pharmaconomics.com/e/293
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:OTLK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR